Work

Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)

Year: 2011

Type: article

Source: Nature Immunology

DOI: 10.1038/ni.2081

Authors: Dongxu Sun, Michael Novotny, Katarzyna Bulek, Caini Liu, Xiaoxia Li, Thomas Hamilton

Institutions: Cleveland Clinic, Cleveland Clinic Research

Language: English

Topic: RNA Research and Splicing

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Neurological Disorders and Stroke

Awards: Asthma Inflammation Research, G1842643373, Molecular and Cellular Mechanisms of IL-17 Signaling, Post-transcriptional control of inflammatory gene expression, Molecular Mechanisms for IL-25-mediated Th2 Responses

OpenAlex ID: W2060500374

FWCI: 9.878

Cites: 49

Cited by: 232

Related to: 10